Samin Tobramycin Injection 80mg (Tobramycin)
Tobramycin 40mg
Prescription medication
Samin Pharmaceutical Co., Ltd.
MFDS item code 199901471 · Notified 1999.02.10 · Insurance code 647801091
Treatment of bacterial infections (pneumonia, sepsis, etc.) and eye infections (conjunctivitis, keratitis, etc.)
The injection is used to treat infections caused by various bacteria such as Pseudomonas aeruginosa and Staphylococcus. It is effective against infections of the central nervous system and respiratory tract, such as meningitis, bronchitis, and pneumonia, as well as gastrointestinal infections like peritonitis. It also assists in the treatment of subcutaneous abscess, soft tissue infections, burns, postoperative infections, and bone infections. Additionally, it is used for treating sepsis, severe recurrent pyelonephritis, and cystitis. Meanwhile, ophthalmic solutions and ointments improve symptoms of ophthalmic infections such as blepharitis, dacryocystitis, stye, conjunctivitis, keratitis, and corneal ulcers. These medications effectively treat various bacterial infections.
(Injection) 1. Adults: For severe infections, administer tobramycin 3mg (potency) per Kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency) per Kg of body weight per day may be administered in 3~4 divided doses. When symptoms improve, the dose should be reduced to 3mg (potency) per Kg of body weight per day. Do not administer more than 5mg (potency) per Kg of body weight per day without measuring serum concentrations. The treatment period is usually 7~10 days and may be extended depending on the severity of the infection. In such cases, monitor renal, vestibular, and auditory function (neurotoxicity occurs more frequently when the treatment period is 10 days or longer.). 3. Patients with renal impairment Measure the serum concentration of this medicine whenever possible. After administering an initial dose of 1mg (potency) per Kg of body weight, reduce the dose or extend the dosing interval from the second dose onward. If the serum concentration of this medicine cannot be measured directly, calculate the dose based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, these methods should not be used during dialysis. 1) Dose reduction (dosing interval: 8 hours): If creatinine clearance is 70mL/min or less, or if the serum creatinine concentration is known, calculate the dose by multiplying the dose for patients with normal renal function by the corresponding % value in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for patients with normal renal function by the serum creatinine concentration. 2) Extension of the dosing interval (same dose as for patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer at intervals calculated by multiplying the serum creatinine concentration by 6. Adjust the dose as appropriate according to age and symptoms. <Preparation of this medicine> For intramuscular injection, dissolve in 1.5mL of saline injection or water for injection before use. For intravenous injection in adults, dilute the dose in 50~100mL of saline injection or 5% dextrose injection and administer by intravenous infusion over 20~60 minutes. (Eye drops) For mild to moderate infections, instill 1~2 drops into the infected area every 4 hours. For severe infections, instill 2 drops every hour until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms. (Ophthalmic ointment) For mild to moderate infections, apply approximately 1cm to the infected area 2~3 times daily. For severe infections, apply 1cm to the infected area every 3~4 hours until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms.
(Injection) 2. Children: Administer 6~7.5mg (potency) per Kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Neonates (less than 1 week old): Administer 4mg (potency) per Kg of body weight per day in divided doses every 12 hours. For intravenous injection in children, reduce the volume of diluent proportionally. A drip intravenous infusion over 20 minutes or less should be avoided, as the serum tobramycin concentration may exceed 12ug/mL. It is preferable not to administer this drug mixed with other drugs.
When using this drug in injection form, care should be taken when opening the glass ampoule. If glass fragments are introduced, serious side effects may occur, so extra caution should be applied when using it for children or the elderly. This medication should not be administered to patients with allergies to this drug or similar antibiotics, patients with ear diseases, severe renal impairment, women who are pregnant or breastfeeding, patients with muscle disorders, patients with bronchial asthma, and patients with certain neurological disorders. Patients with impaired kidney or liver function, newborns or premature infants, elderly patients, and patients with poor nutritional status should be particularly careful while using this drug, as there may be symptoms of vitamin deficiency or allergic reactions, and they should be monitored closely. During administration of this drug, there may be symptoms such as dizziness, tinnitus, hearing loss, renal function impairment, skin rashes, or allergic symptoms; any abnormal symptoms should be promptly reported to the medical staff. It is important to use this medication for the minimum duration necessary to reduce the risk of resistant bacteria development, and to regularly check plasma drug concentrations to maintain appropriate dosing. Special caution is needed in patients with reduced renal function or those requiring prolonged administration. Additionally, the risk of renal toxicity or hearing damage may increase when used with other specific medications, so patients should consult with medical staff regarding concomitant medications. Women who are pregnant or breastfeeding must consult with a doctor before using this drug as it may cause adverse effects in newborns. In pediatric and elderly patients, renal function may be weak, so dosing intervals and amounts should be adjusted carefully. In case of overdose, severe symptoms such as reduced renal function, hearing loss, and shortness of breath may occur, and emergency treatment should be sought if these symptoms arise. This drug may lose its efficacy when mixed with beta-lactam antibiotics, so it is advisable to administer them using different routes. When using the ophthalmic solution or ointment form, irritation or inflammation may occur in the eye, so if symptoms develop, discontinuation and consultation with a doctor are necessary. Moreover, contact lens wear should be avoided during treatment, and caution should be observed when driving or operating machinery. This drug should not be injected directly into the eye, and care should be taken to avoid contact between the tube tip and the eye. Finally, some bacteria have reported resistance to this drug, so it is important to check the susceptibility of the infection-causing bacteria and develop an appropriate treatment plan.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid contact with air and should ideally be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help retain the drug's effectiveness and ensure safe use.
A colorless to pale yellowish transparent liquid contained in a colorless transparent ampoule
2mL-50 ampoules per box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tobramycin 40mg
Prescription medication
Samin Pharmaceutical Co., Ltd.
Tobramycin 40mg
Injections · Prescription medication
(Co., Ltd.) Daewoong Pharmaceutical
Tobramycin 300mg
Eye drops · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Tobramycin 40mg
Prescription medication
Alvogen Korea Co., Ltd.
Tobramycin 50mg
Injections · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
Tobramycin 3mg
Eye drops · Prescription medication
Samchundang Pharmaceutical Co., Ltd.
Tobramycin
Prescription medication
You & Life Science Co., Ltd.
Tobramycin 3mg
Eye drops · Prescription medication
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.